Non-representative sampling detected during internal audit – root cause analysis for sampling failures


Published on 26/04/2026

Root Cause Analysis of Non-Representative Sampling Detected During Internal Audit

When non-representative sampling is detected during an internal audit, it can raise significant concerns regarding product quality, compliance, and safety. Such signals typically indicate larger systemic issues, necessitating a thorough investigation into the underlying causes. This article will provide a structured approach to investigate these sampling failures effectively, empowering quality assurance (QA), quality control (QC), and manufacturing professionals to identify, analyze, and remediate deviations.

By the end of this article, readers will gain insights into the symptoms that may indicate non-representative sampling, explore the probable causes, and understand how to implement effective corrective and preventive actions (CAPA). This structured approach will ensure that organizations not only rectify the issue but also enhance their overall sampling processes and inspection readiness.

Symptoms/Signals on the Floor or in the Lab

Non-representative sampling can manifest itself through various signals during an internal audit or in routine quality checks. Identifying these symptoms is

crucial for prompting further investigation. The following are common indicators:

  • Inconsistencies in Lab Results: Variability in test results from batches that should show uniformity can indicate flawed sampling practices.
  • User Complaints: Feedback from operators or QA personnel about discrepancies in material quality may highlight underlying sampling challenges.
  • Deviation Reports: Documentation of out-of-specification (OOS) results tied to specific batches suggests sampling issues.
  • Review of Vendor Performance: Unexpected changes in supplier reliability or quality reports could correlate with sampling practices.
  • Unverified or Uncalibrated Equipment: Results from instruments that lack proper calibration can skew data accuracy, leading to sampling flaws.

Recognizing these signals initiates the process of investigation, allowing professionals to act swiftly and appropriately.

Likely Causes

When examining non-representative sampling, it is essential to consider possible causes through a categorical lens: Materials, Method, Machine, Man, Measurement, and Environment (the 6 M’s).

Category Likely Causes
Materials Quality of raw materials, improper storage conditions, expired shelf life.
Method Incorrect sampling methodology, failure to follow SOPs, inadequate training of personnel.
Machine Malfunctioning equipment, lack of maintenance, inadequate calibration.
Man Personnel errors, insufficient training, lack of awareness about GMP practices.
Measurement Inaccurate measurement tools, uncalibrated devices, sample integrity concerns.
Environment Inconsistent environmental conditions during sampling, contamination risks from surroundings.
Pharma Tip:  Sampler training deficiency during deviation investigation – CAPA to prevent recurrence

Understanding the categories of likely causes allows for targeted inquiry during the investigation.

Immediate Containment Actions (first 60 minutes)

Upon identifying signals indicative of non-representative sampling, immediate containment actions are vital to preventing further impact on product quality. The following steps should be executed within the first 60 minutes:

  • Stop the Sampling Process: Halt all ongoing sampling operations to prevent further collection of non-representative samples.
  • Notify Key Stakeholders: Inform relevant teams, including QA, QC, and Production, about the situation to initiate a broader investigation.
  • Isolate Affected Materials: Segregate materials or products linked to the suspect sampling to minimize contamination risks.
  • Review Existing Samples: Conduct an immediate review of any samples in transit or awaiting testing to assess potential impact.
  • Document Findings: Maintain a record of actions taken during this initial phase, including timestamps and responsible personnel.

Timely containment can limit the extent of the impact on product quality and safety.

Investigation Workflow

A structured investigation workflow will facilitate the identification of the root cause. The following data should be collected and analyzed:

  • Sampling Records: Review protocols, worksheets, and logs for inconsistencies or deviations from standard practices.
  • Batch Histories: Examine batch manufacturing records (BMR), including any prior deviations related to the same raw materials.
  • Vendor Documentation: Analyze supplier qualification records, including audits and performance evaluations, to assess the reliability of raw materials.
  • Environmental Monitoring: Review environmental conditions documented during sample collection, such as temperature, humidity, and potential contamination sources.
  • Personnel Interviews: Conduct conversations with staff involved to gather insights into the procedures followed, challenges faced, and any anomalies observed.

Collecting this data will provide a comprehensive picture of the processes in question, allowing for more accurate interpretation of findings.

Root Cause Tools

Various root cause analysis tools can guide the investigation of non-representative sampling. The most effective include:

  • 5-Why Analysis: This tool helps uncover the underlying reasons for a problem by repeatedly asking “why” (up to five times). Use it when the issue seems simple but results in significant consequences.
  • Fishbone Diagram (Ishikawa): This method visually maps out the causes of a problem through categories, making it easy to identify contributors across various dimensions. Ideal for complex issues with multiple potential causes.
  • Fault Tree Analysis: A more quantitative method that identifies root causes based on logical relationships between failures and system components. Use this for highly technical issues requiring precise data.
Pharma Tip:  Sampling plan not risk-based during internal audit – preventing false OOS results

Professionals should choose the appropriate tool based on the complexity and context of the sampling failure to identify root causes accurately.

CAPA Strategy

A robust Corrective and Preventive Action (CAPA) strategy is critical for rectifying identified issues and preventing future occurrences. This strategy should encompass:

  • Correction: Address immediate concerns by retraining affected personnel, recalibrating measurement tools, or adjusting sampling methodologies.
  • Corrective Action: Implement system-wide corrections, such as revising standard operating procedures (SOPs), enhancing training programs, or conducting a comprehensive audit of vendor qualification processes.
  • Preventive Action: Establish long-term measures, including routine validation of processes and tools, regular training updates, and routine environmental monitoring assessments.

Documenting each step of the CAPA process, including root causes and actions taken, is essential for regulatory compliance and audit readiness.

Control Strategy & Monitoring

An effective control strategy will preserve improvements achieved through the CAPA process, ensuring ongoing quality and compliance. Key components include:

  • Statistical Process Control (SPC): Implement SPC techniques to monitor trends and variability in sampling processes over time, fostering proactive adjustments.
  • Regular Sampling Audits: Conduct routine audits of sampling practices and systems to confirm adherence to SOPs and protocols.
  • Defined Sampling Alarms: Set parameters that trigger alerts for deviations from expected sampling conditions (e.g., temperature or humidity out-of-range).
  • Periodic Verification: Reassess sampling tools and methods periodically to confirm that they continue to function correctly and yield representative results.

These strategies will help sustain optimal sampling practices long-term.

Validation / Re-qualification / Change Control Impact

In cases of substantial findings, consider the implications for validation, re-qualification, and change control:

  • Validation Impact: Any significant alterations to sampling methods or processes may necessitate revisiting validation protocols to ensure compliance with regulatory standards.
  • Re-qualification Requirements: If sampling equipment or methods are adjusted, re-qualification may be needed to confirm reliability and accuracy.
  • Change Control Processes: Implement a change control process to document any adjustments made to material handling or sampling methodologies as a result of the investigation.

Systematic approaches in validation and change control will align operations with regulatory expectations, enhancing compliance efforts.

Inspection Readiness: What Evidence to Show

Ensuring inspection readiness is crucial, particularly after deviations linked to sampling failures. Key documentation includes:

  • Records of Deviations: Document every step taken in response to the incident, including findings, actions, and follow-up assessments.
  • Training Logs: Maintain updated training documentation for personnel involved in sampling processes to demonstrate adherence to SOPs.
  • Batch Documentation: Ensure that batch records accurately reflect the findings and corrective actions taken, showing traceability and accountability.
  • Environmental Monitoring Reports: Present environmental data during inspections to support arguments for appropriate sampling conditions.
Pharma Tip:  Improper sample storage during incoming material receipt – GMP expectations for material sampling

Preparing this documentation not only demonstrates compliance during audits but also builds credibility in quality management practices.

FAQs

What is non-representative sampling?

Non-representative sampling occurs when collected samples do not accurately reflect the quality or properties of the whole batch, leading to misleading test results.

Why is non-representative sampling a concern?

It can compromise product quality, leading to out-of-specification (OOS) conditions and potential regulatory ramifications.

What are the common causes of sampling errors?

Common causes include improper methodology, inadequate personnel training, equipment malfunction, and environmental factors.

How can I ensure my sampling process is compliant with regulations?

Adhere to established SOPs, conduct regular training, and maintain thorough documentation to ensure compliance with regulatory standards.

What immediate actions should I take if I detect non-representative sampling?

Cease all sampling operations, notify relevant stakeholders, isolate affected materials, and document your findings promptly.

Related Reads

What CAPA actions are best for addressing sampling failures?

Corrective actions, like retraining and updating SOPs, coupled with preventive measures, such as ongoing audits and process validations, can effectively address these failures.

How often should I audit my sampling processes?

Regular audits should occur at defined intervals or when significant changes are made to procedures or materials.

What role does environmental monitoring play in sampling accuracy?

Environmental conditions during sampling must be controlled and monitored to ensure samples remain representative and free from contamination.

Is vendor qualification important for mitigating sampling failures?

Yes, diligent vendor qualification processes are essential for ensuring raw materials meet quality standards, thereby reducing sampling risks.

How should I prepare for a GMP inspection following a sampling deviation?

Document all actions taken, maintain training logs, and ensure batch records reflect corrective actions to showcase your organization’s resolution strategies.

Can a minor sampling error lead to significant regulatory consequences?

Yes, even minor sampling errors can result in product recalls, regulatory warnings, and compromised patient safety, highlighting the importance of rigorous sampling practices.

What tools can help me analyze the root cause of sampling issues?

Utilizing tools such as 5-Why Analysis, Fishbone Diagrams, and Fault Tree Analysis can effectively uncover root causes of sampling failures.

Also Read